Newstral
Article
Forbes on 2024-05-13 14:02
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug Prices
Related news
- Bernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And WegovyForbes
- Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyForbes
- Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings Amid Booming Demand For Weight Loss And Diabetes DrugsForbes
- Inside Novo Nordisk, the Company Behind Ozempic and WegovyThe New York Times
- MNovo Nordisk sues pharmacies over impure Wegovy, Ozempic dupesmvtelegraph.com
- Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker’s ArsenalForbes
- TNovo Nordisk, Eli Lilly leap as Ozempic show promise in kidney patient treatmentthestreet.com
- Why Bernie Sanders’ Ozempic crusade is misguidedDallas News
- TNovo Nordisk Sued By Woman Claiming Negative Ozempic Side Effectstmz.com
- Novo Nordisk layoffs bypass Claytonnewsobserver.com
- Novo Nordisk AS: Prescriptions surge for Novo Nordisk’s Ozempic and similar drugsFinancial Times
- Novo Nordisk braces for generic challenge to Ozempic, Wegovy in Chinastaradvertiser.com
- How little Denmark got homegrown giant Novo Nordisk to lower Ozempic pricesSan Jose Mercury News
- TOzempic And Wegovy Side Effects Prompt Safety Concerns For Novo Nordiskthefloridastar.com
- Ozempic maker Novo Nordisk surges past Tesla with market value of $566BNew York Post
- Ozempic steals the show at the Oscars, but not in the way Novo Nordisk intendedbocaratontribune.com
- FG, Novo Nordisk team up against diabetesvanguardngr.com
- Novo Nordisk sees increased profits despite pandemictimesofmalta.com
- Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid ShortagesForbes
- Ozempic maker Novo plans another $4.1 billion US factory - Tue, 25 Jun 2024 PSTsyndication.washingtonpost.com